You are leaving Medscape Education
Cancel Continue
News & Perspective
Drugs & Diseases
CME & Education
Academy
Video
Decision Point

Specialty: Multispecialty
Allergy & Immunology
Anesthesiology
Business of Medicine
Cardiology
Critical Care
Dermatology
Diabetes & Endocrinology
Emergency Medicine
Family Medicine
Gastroenterology
General Surgery
Hematology - Oncology
HIV/AIDS
Hospital Medicine
Infectious Diseases
Internal Medicine
Multispecialty
Nephrology
Neurology
Ob/Gyn & Women's Health
Oncology
Ophthalmology
Orthopedics
Pathology & Lab Medicine
Pediatrics
Plastic Surgery
Psychiatry
Public Health
Pulmonary Medicine
Radiology
Rheumatology
Transplantation
Urology
Interprofessional
Shared Decision Making
Nurses
Pharmacists
Edition: English

Medscape

English
Deutsch
Español
Français
Português
UKNew

Univadis

Sign Up It's Free!
English Edition

Medscape

Univadis

    X
    Univadis from Medscape

    No Results

      Wednesday, December 6, 2023
      News & Perspective Drugs & Diseases CME & Education Academy Video Decision Point
      Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
       
       

      CME/CE

      Framing the Conversation With Parents About the HPV Vaccine

      • Authors: Larry Pickering, MD; Jay E. Berkelhamer, MD; Jamie Loehr, MD; Katherine Brewer, MSN, RN
      • CME/CE Released: 7/18/2014
      • THIS ACTIVITY HAS EXPIRED FOR CREDIT
      • Valid for credit through: 7/18/2015, 11:59 PM EST
      Start Activity

      Target Audience and Goal Statement

      This activity is intended for pediatricians, family medicine physicians, and nurses.

      The goal of this activity is to educate clinicians on the importance of the human papillomavirus (HPV) vaccine for children approaching adolescence and to provide strategies to educate parents about the importance of the vaccine for their child’s well-being.

      Upon completion of this activity, participants will be able to:

      1. Describe the burden of HPV-related disease in the United States
      2. Interpret the Advisory Committee on Immunization Practices recommendations for HPV vaccination
      3. Identify successful strategies for improving HPV vaccination rates

      Disclosures

      As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

      Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.

      Author(s)

      • Larry Pickering, MD

        Adjunct Professor of Pediatrics, Emory University School of Medicine; Senior Advisor to the Director, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia

        Disclosures

        The opinions expressed are those of Dr Pickering and do not necessarily reflect the views of Emory University or Emory Healthcare. Dr Pickering’s participation in this activity does not constitute or imply endorsement by Emory University or Emory Healthcare.Disclosure: Larry Pickering, MD, has disclosed no relevant financial relationships.

        Dr Pickering does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

        Dr Pickering does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

      • Jay E. Berkelhamer, MD

        Adjunct Professor of Pediatrics, Emory University School of Medicine and Morehouse School of Medicine, Atlanta, Georgia

        Disclosures

        The opinions expressed are those of Dr Berkelhamer and do not necessarily reflect the views of Emory University or Emory Healthcare. Dr Berkelhamer’s participation in this activity does not constitute or imply endorsement by Emory University or Emory Healthcare.

        Disclosure: Jay E. Berkelhamer, MD, has disclosed no relevant financial relationships.

        Dr Berkelhamer does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

        Dr Berkelhamer does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

      • Jamie Loehr, MD

        Cayuga Family Medicine, Ithaca, New York

        Disclosures

        Disclosure: Jamie Loehr, MD, has disclosed no relevant financial relationships.

        Dr Loehr does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

        Dr Loehr does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

      • Katherine Brewer, RN, MSN

        Senior Policy Analyst, Department of Nursing Practice and Policy, American Nurses Association, Silver Spring, Maryland

        Disclosures

        Disclosure: Katherine Brewer, RN, MSN, has disclosed no relevant financial relationships.

        Ms Brewer does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

        Ms Brewer does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

      Editor(s)

      • Susan L. Smith, MN, PhD

        Lead Scientific Director, Medscape, LLC

        Disclosures

        Disclosure: Susan L. Smith, MN, PhD, has disclosed no relevant financial relationships.

      CME Reviewer / Nurse Planner

      • Amy Bernard, MS, BSN, RN-BC

        Lead Nurse Planner, Medscape, LLC

        Disclosures

        Disclosure: Amy Bernard, MS, BSN, RN-BC, has disclosed no relevant financial relationships.

      Accreditation Statements

        For Physicians

      • Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

        Medscape, LLC designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

        Medscape, LLC staff have disclosed that they have no relevant financial relationships.

        Contact This Provider

        For Nurses

      • Medscape, LLC is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

        Awarded 0.75 contact hour(s) of continuing nursing education for RNs and APNs; 0.75 contact hours are in the area of pharmacology.

        Contact This Provider

      For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

      Instructions for Participation and Credit

      There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

      This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

      Follow these steps to earn CME/CE credit*:

      1. Read the target audience, learning objectives, and author disclosures.
      2. Study the educational content online or printed out.
      3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

      You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

      *The credit that you receive is based on your user profile.

      From Medscape Education Public Health & Prevention
      CME/CE

      Framing the Conversation With Parents About the HPV Vaccine

      Authors: Larry Pickering, MD; Jay E. Berkelhamer, MD; Jamie Loehr, MD; Katherine Brewer, MSN, RNFaculty and Disclosures
      THIS ACTIVITY HAS EXPIRED FOR CREDIT

      CME/CE Released: 7/18/2014

      Valid for credit through: 7/18/2015, 11:59 PM EST

      processing....

      References

      1. Centers for Disease Control and Prevention (CDC). National and state vaccination coverage among adolescents aged 13-17 years -- United States, 2012. MMWR Morb Mortal Wkly Rep. 2013;62:685-693. Abstract
      2. Centers for Disease Control and Prevention (CDC). Human papillomavirus vaccination coverage among adolescent girls, 2007-2012, and postlicensure vaccine safety monitoring, 2006-2013--United States. MMWR Morb Mortal Wkly Rep. 2013;62:591-595. Abstract
      3. Satterwhite CL, Torrone E, Meites E, et al. Sexually transmitted infections among U.S. women and men: prevalence and incidence estimates, 2008. Sex Transm Dis. 2013;40:187-193. Abstract
      4. Centers for Disease Control and Prevention (CDC). Human papillomavirus-associated cancers -- United States, 2004-2008. MMWR. 2012:61:258-261. Abstract
      5. Centers for Disease Control and Prevention. Human papillomavirus (HPV)-associated cancers 2013. http://www.cdc.gov/cancer/hpv/statistics/cases.htm. Accessed June 16, 2014.
      6. Dunne EF, Markowitz LE, Saraiya M, et al. CDC grand rounds: Reducing the burden of HPV-associated cancer and disease. MMWR Morb Mortal Wkly Rep. 2014;63:69-72. Abstract
      7. Jemal A, Simard EP, Dorell C, et al. Annual report to the nation on the status of cancer, 1975-2009, featuring the burden and trends in human papillomavirus (HPV)-associated cancers and HPV vaccination coverage levels. J Natl Cancer Inst. 2013;105:175-201. Abstract
      8. Centers for Disease Control and Prevention (CDC). National program of cancer registries (NPCR). United States Cancer Statistics (USCS). 1999-2010 Cancer Incidence and Mortality Data. http://apps.nccd.cdc.gov/uscs/. Accessed June 23, 2014.
      9. Kyrgiou M, Koliopoulos G, Martin-Hirsch P, et al. Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis. Lancet. 2006;367:489-498. Abstract
      10. Arbyn M, Kyrgiou M, Simoens C, et al. Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis. BMJ. 2008;337:a1284.
      11. Chaturvedi AK, Engels EA, Pfeiffer RM, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol. 2011;29:4294-4301. Abstract
      12. Centers for Disease Control and Prevention (CDC). FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep. 2010;59:626-629. Abstract
      13. Markowitz LE, Dunne EF, Saraiya M, et al.; Centers for Disease Control and Prevention (CDC); Advisory Committee on Immunization Practices (ACIP). Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2007;56:1-24. Abstract
      14. Centers for Disease Control and Prevention (CDC). Recommendations on the use of quadrivalent human papillomavirus vaccine in males -- Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep. 2011;60:1705-1708. Abstract
      15. Noronha AS, Markowitz LE, Dunne EF. Systematic review of human papillomavirus vaccine coadministration. Vaccine. 2014;32:2670-2674. Abstract
      16. Oster NV, McPhillips-Tangum CA, Averhoff F, Howell K. Barriers to adolescent immunization: a survey of family physicians and pediatricians. J Am Board Fam Pract. 2005;18:13-19. Abstract
      17. Markowitz LE, Hariri S, Lin C, et al. Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition Examination Surveys, 2003-2010. J Infect Dis. 2013;208:385-393. Abstract
      18. Flagg EW, Schwartz R, Weinstock H. Prevalence of anogenital warts among participants in private health plans in the United States, 2003-2010: potential impact of human papillomavirus vaccination. Am J Public Health. 2013;103:1428-1435. Abstract
      19. Ali H, Guy RJ, Wand H, et al. Decline in in-patient treatments of genital warts among young Australians following the national HPV vaccination program. BMC Infect Dis. 2013;13:140.
      20. Klein NP, Hansen J, Chao C, et al. Safety of quadrivalent human papillomavirus vaccine administered routinely to females. Arch Pediatr Adolesc Med. 2012;166:1140-1148. Abstract
      21. Arnheim-Dahlström L, Pasternak B, Svanström H, Sparén P, Hviid A. Autoimmune, neurological, and venous thromboembolic adverse events after immunisation of adolescent girls with quadrivalent human papillomavirus vaccine in Denmark and Sweden: cohort study. BMJ. 2013;347:f5906.
      22. Kroger AT, Sumaya CV, Pickering AK, Atkinson WL. General Recommendations on Immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2011;60:1-60.
      23. Dorell CG, Yankey D, Santibanez TA, Markowitz LE. Human papillomavirus vaccination series initiation and completion, 2008-2009. Pediatrics. 2011;128:830-839. Abstract
      24. Perkins R, Tipton H, Shu E, et al. Attitudes toward HPV vaccination among low-income and minority parents of sons: a qualitative analysis. Clin Pediatr (Phila). 2013;52:231-240. Abstract
      25. Perkins RB, Apte G, Marquez C, et al. Factors affecting human papillomavirus vaccine use among white, black and latino parents of sons. Pediatr Infect Dis J. 2013;32:e38-e44. Abstract
      26. Centers for Disease Control and Prevention. Preteens and teen vaccines. Tips and time-savers for talking with parents about HPV vaccine. http://www.cdc.gov/vaccines/who/teens/for-hcp-tipsheet-hpv.html. Accessed June 23, 2014.
      27. Krüger KS, Hansen BT, Tryggvadóttir L, et al. Long-term effectiveness of Gardasil™ in the Nordic countries. Program of the 28th International Papillomavirus Conference; San Juan, Puerto Rico; November 30-December 6, 2012.
      28. Saah A, Protocol 018 investigators. Long-term extension study of Gardasil in adolescents; results through month 96. Program of the 28th International Papillomavirus Conference; San Juan, Puerto Rico; November 30-December 6, 2012.
      29. Nygård M, Dillner J, Marshall B, et al. A long term follow-up study of the immunogenicity of the quadrivalent HPV (qHPV) vaccine in Scandinavia and Iceland. Program of the 28th International Papillomavirus Conference; San Juan, Puerto Rico; November 30-December 6, 2012.
      « Return to: Framing the Conversation With Parents About the HPV Vaccine
      CME/CE Information
      • Print
      Find Us On
      About
      About Medscape Privacy Policy Editorial Policy Cookies Terms of Use Advertising Policy Help Center
      Membership
      Become a Member About You Professional Information Newsletters & Alerts Market Research
      App
      Medscape
      WebMD Network
      Medscape Live Events WebMD MedicineNet eMedicineHealth RxList WebMD Corporate Medscape UK
      Editions
      English Deutsch Español Français Português UK
      All material on this website is protected by copyright, Copyright © 1994-2023 by WebMD LLC. This website also contains material copyrighted by 3rd parties.